Long-Acting Injectable Second-Generation Antipsychotics Improve Negative Symptoms and Suicidal Ideation in Recent Diagnosed Schizophrenia Patients: A 1-Year Follow-up Pilot Study

Long-acting injectable second-generation antipsychotics (LAI-SGA) are typically used to maintain treatment adherence in patients with chronic schizophrenia. Recent research suggests that they may also provide an effective treatment strategy for patients with early-phase disease. The aim of this stud...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Schizophr Res Treatment
Autors principals: Corigliano, Valentina, Comparelli, Anna, Mancinelli, Iginia, Montalbani, Benedetta, Lamis, Dorian A., De Carolis, Antonella, Erbuto, Denise, Girardi, Paolo, Pompili, Maurizio
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6136552/
https://ncbi.nlm.nih.gov/pubmed/30245878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/4834135
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars